FRANKLIN LAKES, N.J. , Aug. 21, 2019 /PRNewswire/ -- BD ( Becton, Dickinson and Company ) (NYSE: BDX), a leading global medical technology company, announced today that it will present at the following upcoming investor healthcare conferences: Wells Fargo Securities 2019 Healthcare Conference

BD appreciates the Food and Drug Administration’s (FDA) thoughtful, updated recommendations regarding the use of paclitaxel-coated devices following the Advisory Committee meeting of the Circulatory System Devices Panel in June. While the Panel concluded that a late mortality signal was present,

- As reported, revenues of $4.350 billion increased 1.7 percent. - On a comparable, currency-neutral basis, revenues increased 5.7 percent. - As reported, diluted earnings per share of $1.51 decreased 25.6 percent. - As adjusted, diluted earnings per share of $3.08 increased 5.8 percent, or 14.8

FRANKLIN LAKES, N.J. , July 23, 2019 /PRNewswire/ --  BD ( Becton, Dickinson and Company ) (NYSE: BDX), a leading global medical technology company, today issued its 2018 Sustainability Report, focusing on management of the environmental, social and governance factors that support the company's

FRANKLIN LAKES, N.J. , July 22, 2019 /PRNewswire/ -- The Board of Directors of BD ( Becton, Dickinson and Company ) (NYSE: BDX) has declared a quarterly dividend of $0.77 per common share, payable on September 30, 2019 to holders of record on September 9 , 2019.  The indicated annual dividend rate

FRANKLIN LAKES, N.J. , July 18, 2019 /PRNewswire/ -- BD ( Becton, Dickinson and Company ) (NYSE: BDX), a leading global medical technology company, today provided an update on two voluntary recalls related to certain Alaris™ Pump Modules Model 8100 manufactured between April 2011 and June 2017 and